The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Rurelec will continue to explore its options for the 701 DU 125MW Turbines, including a potential sale. One option under consideration is whether it is possible to ring fence the value of the turbines for shareholders whilst at the same time making the Company attractive for new business opportunities through which it can create shareholder value. Further updates on this proposal will be provided in due course if it progresses. The Directors will also be reviewing potential acquisition opportunities as they arise.
-------------------------------------
Not even an RNS on your first dividend in 15 years , very disappointing BOD .
NOT outstanding